Loading resource…

Ministry of Health, Uganda
The document announces Uganda's transition to a one‑dose HPV vaccine regimen for immunocompetent 10‑year‑old girls, while maintaining a two‑dose schedule for immunocompromised girls, including those living with HIV. It references WHO's 90‑70‑90 targets for cervical cancer elimination and highlights the country's high disease burden. The memorandum also calls for integrated prevention packages, mass awareness campaigns, and timely referral for women with cervical disease. It reflects recommendations from the Uganda NITAG and aligns with WHO SAGE guidance issued in 2022.
No account needed
Uganda: HPV doses depend on immune status
“In this regard, starting January 2025, the following new guidelines will be implemented: 1. For immunocompetent girls aged 10 years, one dose of the HPV vaccine will be administered. 2. For immunocompromised 10-year-old girls, including those living with HIV, two doses of the HPV vaccine will continue to be provided. The second dose will be administered at care clinics.”